Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007–2011): Evidence leading to policy enhancement-Reference-Cited by-同舟云学术

Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007–2011): Evidence leading to policy enhancement

Published:2018-04-11 Issue:4 Volume:13 Page:e0193903
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Parmar Malik M.^ORCID,Sachdeva Kuldeep Singh,Dewan Puneet K.,Rade Kiran,Nair Sreenivas A.,Pant Rashmi,Khaparde Sunil D.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. From Where Are Tuberculosis Patients Accessing Treatment in India? Results from a Cross-Sectional Community Based Survey of 30 Districts;S Satyanarayana;PLOS ONE,2011

2. Central TB Division, Directorate General of Health Services. TB India 2014—RNTCP Annual Status Report. 2014:http://www.tbcindia.gov.in/showfile.php?lid=3142

3. Central TB Division, Directorate General of Health Services. RNTCP Performance Report - 1st Quarter 2011: http://www.tbcindia.gov.in/showfile.php?lid=2978

4. Central TB Division, Directorate General of Health Services. DOTS-Plus Guidelines Jan 2010: http://health.bih.nic.in/Docs/Guidelines/Guidelines-DOTS-Plus.pdf

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers to engagement in the care cascade for tuberculosis disease in India: A systematic review of quantitative studies;PLOS Medicine;2024-05-28

2. Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis;Nature Communications;2024-05-09

3. Predictors of Treatment Outcome and Drug Resistance in Tuberculosis Patients at Yirgalem General Hospital, Sidama Region, South Ethiopia: A Retrospective Cohort Study;2024-02-12

4. Bedaquiline’s Safety Profile Monitoring in India: Considerations for Future - A Systematic Review;Current Drug Safety;2024-02

5. Tuberculosis and the Effectiveness of the Revised National Tuberculosis Control Program (RNTCP) to Control Tuberculosis: A Narrative Review;Cureus;2023-12-31